These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease. Shapiro H; Tehilla M; Attal-Singer J; Bruck R; Luzzatti R; Singer P Clin Nutr; 2011 Feb; 30(1):6-19. PubMed ID: 20619513 [TBL] [Abstract][Full Text] [Related]
7. Omega-3 polyunsaturated fatty acids: a specific liver drug for non-alcoholic fatty liver disease (NAFLD). Xin YN; Xuan SY; Zhang JH; Zheng MH; Guan HS Med Hypotheses; 2008 Nov; 71(5):820-1. PubMed ID: 18752901 [No Abstract] [Full Text] [Related]
8. Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. Capanni M; Calella F; Biagini MR; Genise S; Raimondi L; Bedogni G; Svegliati-Baroni G; Sofi F; Milani S; Abbate R; Surrenti C; Casini A Aliment Pharmacol Ther; 2006 Apr; 23(8):1143-51. PubMed ID: 16611275 [TBL] [Abstract][Full Text] [Related]
9. Role of nitric oxide in the treatment of non-alcoholic fatty liver by omega-3 fatty acids. Beyazit Y; Purnak T; Kekilli M Aliment Pharmacol Ther; 2010 Jul; 32(2):303-4. PubMed ID: 20636624 [No Abstract] [Full Text] [Related]
10. Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: a preliminary study. Sofi F; Giangrandi I; Cesari F; Corsani I; Abbate R; Gensini GF; Casini A Int J Food Sci Nutr; 2010 Dec; 61(8):792-802. PubMed ID: 20465434 [TBL] [Abstract][Full Text] [Related]
11. Omega-3 fatty acids reduce hepatic steatosis and consequently attenuate ischemia-reperfusion injury following partial hepatectomy in rats. Marsman HA; Heger M; Kloek JJ; Nienhuis SL; ten Kate FJ; van Gulik TM Dig Liver Dis; 2011 Dec; 43(12):984-90. PubMed ID: 21840275 [TBL] [Abstract][Full Text] [Related]
12. B vitamin and/or ω-3 fatty acid supplementation and cancer: ancillary findings from the supplementation with folate, vitamins B6 and B12, and/or omega-3 fatty acids (SU.FOL.OM3) randomized trial. Andreeva VA; Touvier M; Kesse-Guyot E; Julia C; Galan P; Hercberg S Arch Intern Med; 2012 Apr; 172(7):540-7. PubMed ID: 22331983 [TBL] [Abstract][Full Text] [Related]
13. Reversal of hepatic steatosis by omega-3 fatty acids measured non-invasively by (1) H-magnetic resonance spectroscopy in a rat model. Marsman HA; Heger M; Kloek JJ; Nienhuis SL; van Werven JR; Nederveen AJ; Ten Kate FJ; Stoker J; van Gulik TM J Gastroenterol Hepatol; 2011 Feb; 26(2):356-63. PubMed ID: 21261727 [TBL] [Abstract][Full Text] [Related]
14. Omega-3 fatty acid supplementation does not prevent serious vascular events in people with diabetes. Magavern EF; Khong TK Drug Ther Bull; 2019 Oct; 57(10):150-151. PubMed ID: 31554605 [No Abstract] [Full Text] [Related]
15. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder. Young GS; Conquer JA; Thomas R Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207 [TBL] [Abstract][Full Text] [Related]
16. Effect of omega-3 fatty acids supplementation on endothelial function: a meta-analysis of randomized controlled trials. Wang Q; Liang X; Wang L; Lu X; Huang J; Cao J; Li H; Gu D Atherosclerosis; 2012 Apr; 221(2):536-43. PubMed ID: 22317966 [TBL] [Abstract][Full Text] [Related]
17. Omega-3 fatty acids: a promising alternative treatment approach for patients with nonalcoholic fatty liver disease. Beyazit Y; Purnak T; Kekilli M Dig Dis Sci; 2010 Aug; 55(8):2422-3; author reply 2423. PubMed ID: 20521114 [No Abstract] [Full Text] [Related]
18. Supplementation of omega-3 fatty acids in patients with ankylosing spondylitis. Sundström B; Stålnacke K; Hagfors L; Johansson G Scand J Rheumatol; 2006; 35(5):359-62. PubMed ID: 17062435 [TBL] [Abstract][Full Text] [Related]